Assignee
CANCER THERAPEUTICS LABORATORIES INC
US·2 granted patents·2 pending applications·2 citations·filing 2018–2025
Top patents by PatentIndex Score
4 records- 0189US12258421B2Humanized anti-nuclear antibodies for targeting necrosis in cancer therapyCANCER THERAPEUTICS LABORATORIES INC·Filed 2022·Granted Mar 25, 2025·1 cites·17 claims
- 0281US11384157B2Humanized anti-nuclear antibodies for targeting necrosis in cancer therapyCANCER THERAPEUTICS LABORATORIES INC·Filed 2018·Granted Jul 12, 2022·1 cites·20 claims
- 0365US2025215114A1Humanized anti-nuclear antibodies for targeting necrosis in cancer therapyCANCER THERAPEUTICS LABORATORIES INC·Filed 2025·Application pending·0 cites
- 0442US2020147230A1Tumor necrosis targeting compositions and methodsCANCER THERAPEUTICS LABORATORIES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CANCER THERAPEUTICS LABORATORIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →